SYSTEME D'EXPRESSION POUR UNE THERAPIE GENIQUE SELECTIVE

European patent · EP3404106 · In force

Register entry

Publication number
EP3404106
Application number
EP18182802
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Apr 10, 2014
Published
Nov 21, 2018
Granted
Jun 9, 2021
Protection ends at the latest
Apr 9, 2034
Next annual fee due
Apr 30, 2027
IPC classes
C12N 15/86 (2006.01)
C07K 14/47 (2006.01)
C12N 15/113 (2010.01)
A61K 48/00 (2006.01)
C12N 9/16 (2006.01)
C12N 9/64 (2006.01)
A61K 38/46 (2006.01)
A61K 38/48 (2006.01)
A61P 21/00 (2006.01)
A61P 25/00 (2006.01)
A61P 43/00 (2006.01)
Priority
FR 1353306 11.04.2013
Filing language
French
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. May 1, 2026

    Change

    Published in Swissreg on 01.05.2026

  2. May 1, 2025

    Change

    Published in Swissreg on 01.05.2025

  3. May 1, 2024

    Change

    Published in Swissreg on 01.05.2024

  4. May 1, 2023

    Change

    Published in Swissreg on 01.05.2023

  5. Apr 20, 2022

    Change

    Published in Swissreg on 20.04.2022

  6. Jun 9, 2021

    Granted

    Published in Swissreg on 09.06.2021

Parties

Holder

Centre National de la Recherche Scientifique

3, rue Michel-Ange, 75794 Paris, FR

Genethon

GENETHON

1 bis rue de l'Internationale Boîte Postale 60, 91002 Evry Cedex, FR

Inventor

RICHARD, Isabelle

91100 CORBEIL ESSONNES, FR

BUJ BELLO, Ana Maria

75005 PARIS, FR

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.